A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine
Clinical trial NCT02959190 · COMPLETED
Trial details
- NCT number
- NCT02959190
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-07
- Primary completion
- 2019-08-10
- Enrollment
- 311
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.